Resources

Selected
  • 昊华科技2024年商誉
Type of publications
Regions
Diseases
380 results found
2024 ∙ Riemma, G. Etrusco, A. Laganà, A. S. Torella, M. Vastarella, M. G. Della Corte, L. D'Amato, A. La Verde, M. De Franciscis, P. Cobellis, L.
Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence
Adults COVID-19 Safety
Rating:
Low
2024 ∙ Wong, B. K. Mabbott, N. A.
Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults
Adults COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2024 ∙ Marra, F. Yip, M. Cragg, J. J. Vadlamudi, N. K.
Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations
Adults Older adults Herpes zoster Efficacy/effectiveness Safety
Rating:
Critically low
2024 ∙ Levin, A. Yeung, K. H. T. Hutubessy, R.
Systematic review of cost projections of new vaccine introduction
All age groups Economic aspects
Rating:
Not applicable
2024 ∙ Moradiya, P. Khandelwal, P. Raina, R. Mahajan, R. G.
Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination-Associated Thrombotic Microangiopathy
All age groups COVID-19 Safety
Rating:
Critically low
2024 ∙ Ardura-Garcia, C. Curtis, N. Zimmermann, P.
Systematic review of the impact of intestinal microbiota on vaccine responses
All age groups Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Liu, R. Fan, Y. Patel, A. Liu, H. Du, X. Liu, B. Di Tanna, G. L.
The association between influenza vaccination, cardiovascular mortality and hospitalization: A living systematic review and prospective meta-analysis
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2024 ∙ Horn, E. K. Herrera-Restrepo, O. Acosta, A. M. Simon, A. Jackson, B. Lucas, E.
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies
Americas United States of America Adults Older adults Hepatitis A Economic aspects
Rating:
Not applicable
2024 ∙ Bao, W. He, X. Huang, Y. Liu, R. Li, Z.
The Clinical Effectiveness of Single-Dose Human Papillomavirus Vaccination
All age groups Human papillomavirus (HPV) Administration Efficacy/effectiveness
Rating:
Critically low
2024 ∙ Langer, J. Welch, V. L. Moran, M. M. Cane, A. Lopez, S. M. C. Srivastava, A. Enstone, A. Sears, A. Markus, K. Heuser, M. Kewley, R. Whittle, I.
The Cost of Seasonal Influenza: A Systematic Literature Review on the Humanistic and Economic Burden of Influenza in Older (>= 65 Years Old) Adults
Older adults Influenza Economic aspects
Rating:
Not applicable
Loading...